Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
2.220
+0.030 (1.37%)
At close: May 9, 2025, 4:00 PM
2.220
0.00 (0.00%)
After-hours: May 9, 2025, 7:00 PM EDT

Alto Neuroscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
168.2382.5548.3425.71
Cash & Short-Term Investments
168.2382.5548.3425.71
Cash Growth
103.79%70.75%88.07%-
Accounts Receivable
---1.5
Other Receivables
--0.330.25
Receivables
--0.331.74
Prepaid Expenses
1.080.520.330.24
Other Current Assets
0.032.320.21-
Total Current Assets
169.3485.3949.2227.68
Property, Plant & Equipment
7.71.231.581.06
Other Long-Term Assets
0.50.010.060.05
Total Assets
177.5486.6350.8528.79
Accounts Payable
1.581.071.610.6
Accrued Expenses
7.563.53.670.93
Current Portion of Leases
0.870.130.28-
Other Current Liabilities
-0.92-0.28
Total Current Liabilities
10.015.615.561.81
Long-Term Debt
11.569.869.47-
Long-Term Leases
4.52-0.12-
Total Liabilities
26.0815.4715.151.81
Common Stock
0--0
Additional Paid-In Capital
289.955.372.30.49
Retained Earnings
-138.4-76.97-40.66-12.95
Comprehensive Income & Other
-0.1-0.08-0.05-0.02
Total Common Equity
151.46-71.67-38.41-12.48
Shareholders' Equity
151.4671.1635.7126.98
Total Liabilities & Equity
177.5486.6350.8528.79
Total Debt
16.949.999.87-
Net Cash (Debt)
151.2972.5638.4725.71
Net Cash Growth
108.49%88.61%49.67%-
Net Cash Per Share
6.1519.4511.1610.65
Filing Date Shares Outstanding
27.0726.863.692.41
Total Common Shares Outstanding
26.993.813.692.41
Working Capital
159.3379.7843.6625.87
Book Value Per Share
5.61-18.81-10.40-5.17
Tangible Book Value
151.46-71.67-38.41-12.48
Tangible Book Value Per Share
5.61-18.81-10.40-5.17
Machinery
2.751.271.20.88
Leasehold Improvements
0.25---
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q